# Resources

1. The PRO-ACT database - Design, initial analyses, and predictive features. [Neurology. 2014 Nov 4; 83(19): 1719–1725](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239834/)

2. Pooled Resource Open-Access ALS Clinical Trials Database [PRO-ACT](https://nctu.partners.org/ProACT/)

3. Küffner R, Zach N et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. [Nat Biotechnol. 2015 33:51-7](http://www.nature.com/nbt/journal/v33/n1/full/nbt.3051.html?foxtrotcallback=true)

4. Hothorn T, Jung HH. RandomForest4Life: a Random Forest for predicting ALS disease progression. Amyotroph Lateral Scler Frontotemporal Degener. 2014 15(5-6):444-52

5. Malcolm et al. The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset. [Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 
Volume 17, 2016 - Issue 5-6](
http://www.tandfonline.com/doi/full/10.3109/21678421.2016.1140786?src=recsys)

6. Balendra et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2014, Vol.15(3-4), p.279-284
